Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Riccardo Marconcini"'
Autor:
Stefania Crucitta, Federico Cucchiara, Riccardo Marconcini, Alessandra Bulleri, Simona Manacorda, Annalisa Capuano, Dania Cioni, Amedeo Nuzzo, Evert de Jonge, Ron H. J. Mathjissen, Emanuele Neri, Ron H. N. van Schaik, Stefano Fogli, Romano Danesi, Marzia Del Re
Publikováno v:
Frontiers in Molecular Biosciences, Vol 11 (2024)
Introduction: Immune checkpoint inhibitors (ICIs) represent the standard therapy for metastatic melanoma. However, a few patients do not respond to ICIs and reliable predictive biomarkers are needed.Methods: This pilot study investigates the associat
Externí odkaz:
https://doaj.org/article/8e14b0fdf9504f27a43e5891cecfd741
Autor:
Elisa Giommoni, Roberta Giorgione, Agnese Paderi, Elisa Pellegrini, Elisabetta Gambale, Andrea Marini, Andrea Antonuzzo, Riccardo Marconcini, Giandomenico Roviello, Marco Matucci-Cerinic, David Capaccioli, Serena Pillozzi, Lorenzo Antonuzzo
Publikováno v:
Immuno, Vol 1, Iss 3, Pp 253-263 (2021)
Background: To date, no biomarkers are effective in predicting the risk of developing immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICIs). This study aims to evaluate the association between basal absolu
Externí odkaz:
https://doaj.org/article/89ab038850ba456ea03a27074856e638
Autor:
Riccardo Marconcini, Paolo Fava, Amedeo Nuzzo, Simona Manacorda, Marco Ferrari, Francesco De Rosa, Michele De Tursi, Enrica Teresa Tanda, Francesca Consoli, Alessandro Minisini, Nicola Pimpinelli, Francesca Morgese, Melissa Bersanelli, Marco Tucci, Maristella Saponara, Alessandro Parisi, Marcella Ocelli, Serena Bazzurri, Giulia Massaro, Riccardo Morganti, Isabella Ciardetti, Ignazio Stanganelli
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundBRAF and MEK inhibitors target therapies (TT) and AntiPD1 immunotherapies (IT) are available first-line treatments for BRAF v600 mutant metastatic melanoma patients. ECOG PS (E), baseline LDH (L), and baseline number of metastatic sites (N)
Externí odkaz:
https://doaj.org/article/7ed0a33bb9c64531ab12915da799b5dc
Autor:
Daniele Santini, Tea Zeppola, Marco Russano, Fabrizio Citarella, Cecilia Anesi, Sebastiano Buti, Marco Tucci, Alessandro Russo, Maria Chiara Sergi, Vincenzo Adamo, Luigia S. Stucci, Melissa Bersanelli, Giulia Mazzaschi, Francesco Spagnolo, Francesca Rastelli, Francesca Chiara Giorgi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Laura Pala, Paola Queirolo, Sergio Bracarda, Serena Macrini, Stefania Gori, Alessandro Inno, Federica Zoratto, Enrica T. Tanda, Domenico Mallardo, Maria Grazia Vitale, Thomas Talbot, Paolo A. Ascierto, David J. Pinato, Corrado Ficorella, Giampiero Porzio, Alessio Cortellini
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Background The favourable safety profile and the increasing confidence with immune checkpoint inhibitors (ICIs) might have boosted their prescription in frail patients with short life expectancies, who usually are not treated with standard c
Externí odkaz:
https://doaj.org/article/6d89e6884a4e4f16873bdd6d6f5f5956
Autor:
Riccardo Marconcini, Gaetano Pezzicoli, Luigia Stefania Stucci, Maria Chiara Sergi, Lucia Lospalluti, Camillo Porta, Marco Tucci
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 18, Iss 3 (2022)
Cutaneous Melanoma (CM) is an aggressive cancer whose incidence is increasing worldwide. However, the knowledge of its biology and genes driving cell growth and survival allowed to develop new drugs that have improved PFS and OS of advanced disease.
Externí odkaz:
https://doaj.org/article/e9388c5f09704ab7b77c7534c69772c6
Autor:
Michele Del Vecchio, Vanna Chiarion Sileni, Pietro Quaglino, Gaetana Rinaldi, Alessandro Minisini, Teresa Troiani, Francesca Consoli, Andrea Sponghini, Maria Banzi, Maria Francesca Morelli, Dario Palleschi, Ernesto Rossi, Riccardo Marconcini, Roberta Depenni, Fabrizio Carnevale-Schianca, Ilaria Marcon, Paola Queirolo
Publikováno v:
Cancers, Vol 15, Iss 7, p 1980 (2023)
In patients with B-RAF-mutated cutaneous melanoma, targeted therapies are the treatment of choice to achieve a rapid response. In this multicentric, prospective, observational study, patients with B-RAF-mutated cutaneous melanoma who were treated wit
Externí odkaz:
https://doaj.org/article/1a70be24faad4192a4fd982efa2c7492
Autor:
Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, Katia Cannita, Daniele Santini, Fabiana Perrone, Raffaele Giusti, Marcello Tiseo, Maria Michiara, Pietro Di Marino, Nicola Tinari, Michele De Tursi, Federica Zoratto, Enzo Veltri, Riccardo Marconcini, Francesco Malorgio, Marco Russano, Cecilia Anesi, Tea Zeppola, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Gian Carlo Antonini Cappellini, Federica De Galitiis, Maria Giuseppa Vitale, Francesca Rastelli, Federica Pergolesi, Rossana Berardi, Silvia Rinaldi, Marianna Tudini, Rosa Rita Silva, Annagrazia Pireddu, Francesco Atzori, Rita Chiari, Biagio Ricciuti, Andrea De Giglio, Daniela Iacono, Alain Gelibter, Mario Alberto Occhipinti, Alessandro Parisi, Giampiero Porzio, Maria Concetta Fargnoli, Paolo Antonio Ascierto, Corrado Ficorella, Clara Natoli
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-11 (2019)
Abstract Background Recent evidence suggested a potential correlation between overweight and the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients. Patients and methods We conducted a retrospective study of advanced cancer patients c
Externí odkaz:
https://doaj.org/article/721f0d0be9e345b393f57f040b3f9b1c
Autor:
Francesco Mannavola, Mario Mandala, Annalisa Todisco, Vanna Chiarion Sileni, Marco Palla, Alessandro Marco Minisini, Laura Pala, Francesca Morgese, Lorenza Di Guardo, Luigia Stefania Stucci, Michele Guida, Alice Indini, Pietro Quaglino, Virginia Ferraresi, Riccardo Marconcini, Maria Chiara Tronconi, Ernesto Rossi, Olga Nigro, Marcella Occelli, Alessio Cortellini, Silvia Quadrini, Giuseppe Palmieri, Jacopo Pigozzo, Paolo Antonio Ascierto, Maria Grazia Vitale, Sabino Strippoli, Pier Francesco Ferrucci, Rossana Berardi, Giovanni Randon, Pietro Cardone, Giovanni Schinzari, Franco Silvestris, Marco Tucci
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
BackgroundWe performed a multicenter retrospective observational study to investigate the impact of clinical–pathological features and therapeutic strategies on both the complications and survival of patients with bone metastases (BMs) from maligna
Externí odkaz:
https://doaj.org/article/f7e6e5a9fa7d4cde857b7f04aa464c7d
Autor:
Simone Ribero, Luigia Stefania Stucci, Elena Marra, Riccardo Marconcini, Francesco Spagnolo, Laura Orgiano, Virginia Picasso, Paola Queirolo, Guiseppe Palmieri, Pietro Quaglino, Veronique Bataille
Publikováno v:
Acta Dermato-Venereologica, Vol 98, Iss 7, Pp 624-629 (2018)
As for all types of cancer, the incidence of melanoma increases with age. However, naevus counts (the principal risk factor for melanoma) decrease with age; hence the relationship between ageing and melanoma is complex. Subjects who maintain a high n
Externí odkaz:
https://doaj.org/article/246b992daf3f44299694a367bbe35bb5
Autor:
Piero Ferolla, Alfredo Berruti, Francesca Spada, Maria Pia Brizzi, Toni Ibrahim, Riccardo Marconcini, Dario Giuffrida, Vito Amoroso, Anna La Salvia, Vanja Vaccaro, Antongiulio Faggiano, Annamaria Colao, Marco Volante, Simona Ghizzoni, Paola Mazzanti, Aude Houchard, Nicola Fazio
Publikováno v:
Neuroendocrinology. 113:332-342
Introduction: Lanreotide autogel (LAN) and temozolomide (TMZ) are guidelines-recommended monotherapies for thoracic neuroendocrine tumors (carcinoids; T-NETs), but prospective data for both combined and monotherapies are lacking. ATLANT (NCT02698410)